UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

UnitedHealth Group Inc (NYSE:UNH). has reached an unprecedented milestone as its stock soared to an all-time high of $607.98. This remarkable peak reflects a robust year-over-year... On Friday, TD ...

Shares of UnitedHealth Group (NYSE: UNH) were pulling back in ... According to data from S&P Global Market Intelligence, the stock lost 17% last month. As you can see from the chart, the stock ...

UnitedHealth Group Inc (UNH) stock saw a modest uptick, ending the day at $532.51 which represents a slight increase of $2.74 or 0.52% from the prior close of $529.77. The stock opened at $528.11 and ...

"The people of UnitedHealth Group remain focused on making high-quality ... But Wall Street remains overwhelmingly bullish on the blue chip stock. According to S&P Global Market Intelligence ...

UnitedHealth Group’s stock sinks after profit beat expectations but revenue missed for the first time in more than four years ...

The cyberattack at UnitedHealth Group exposed personal information of 190 million people, leading to a $22 million ransom ...

Shares of UnitedHealth Group Inc. UNH dropped 0.38% to $505.86 Tuesday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index SPX falling 0.43% to ...

We recently compiled a list of the Retirement Stock Portfolio: 10 Healthcare Stocks to Buy. In this article, we are going to take a look at where UnitedHealth Group Incorporated (NYSE:UNH ...

At the close in NYSE, the Dow... UnitedHealth Group (NYSE: NYSE:UNH) reaffirmed its full-year earnings outlook during its third quarter 2024 earnings call, despite facing challenges such as ...

but reputational and regulatory risk could weigh on the stock in 2025. Jeremy Bowman has no position in any of the stocks mentioned. The Motley Fool recommends CVS Health and UnitedHealth Group.